ProMetic Life Sciences Inc. announced that at its 2013 annual and special meeting of shareholders, the shareholders elected Dr. Simon Best as a new board member and appointed as chairman of the board.
Liminal BioSciences Inc.
Equities
PJ2
CA53272L2021
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+23.37% | 47.02B | |
+49.84% | 41.86B | |
-0.94% | 41.76B | |
-4.32% | 28.8B | |
+11.29% | 26.05B | |
-20.92% | 19.15B | |
+3.20% | 12.55B | |
-2.67% | 11.82B | |
+30.23% | 12.34B |